Overview

The Efficacy of Topical Mesalazine Sustained-Release Tablets in Crohn's Disease Patients With Oral Ulcer

Status:
Unknown status
Trial end date:
2017-01-01
Target enrollment:
Participant gender:
Summary
This study aims at evaluating efficacy and safety of topical using Mesalazine Sustained-Release Tablets in in the treatment of oral ulcers in patients with Crohn's disease.
Phase:
Phase 3
Details
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Treatments:
Flavin Mononucleotide
Mesalamine
Riboflavin